Short-read Sequencing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Short-read Sequencing Market, By Application

7.1.  Short-read Sequencing Market, by Application, 2020-2028

7.1.1.    Oncology

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Clinical Investigation

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Reproductive Health

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    HLA Typing/Immune System Monitoring

7.1.4.1.        Market Revenue and Forecast (2016-2028)

7.1.5.    Metagenomics, Epidemiology & Drug Development

7.1.5.1.        Market Revenue and Forecast (2016-2028)

7.1.6.    Agrigenomics & Forensics

7.1.6.1.        Market Revenue and Forecast (2016-2028)

7.1.7.    Consumer Genomics

7.1.7.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Short-read Sequencing Market, By End User

8.1.  Short-read Sequencing Market, by End User, 2020-2028

8.1.1.    Academic Research

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Clinical Research

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Hospitals & Clinics

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Pharma & Biotech Entities

8.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Short-read Sequencing Market, By Technology

9.1.  Short-read Sequencing Market, By Technology , 2020-2028

9.1.1.    Next-Generation Sequencing

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Sanger Sequencing

9.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Short-read Sequencing Market, By Product

10.1.        Short-read Sequencing Market, By Product, 2020-2028

10.1.1.  Instruments

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Consumables

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  Services

10.1.3.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Short-read Sequencing Market, By Workflow

11.1.        Short-read Sequencing Market, By Workflow, 2020-2028

11.1.1.  Pre-Sequencing

11.1.1.1.      Market Revenue and Forecast (2016-2028)

11.1.2.  Sequencing

11.1.2.1.      Market Revenue and Forecast (2016-2028)

11.1.3.  Data Analysis

11.1.3.1.      Market Revenue and Forecast (2016-2028)

Chapter 12.      Global Short-read Sequencing  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Application (2016-2028)

12.1.2.  Market Revenue and Forecast, by End User (2016-2028)

12.1.3.  Market Revenue and Forecast, By Technology  (2016-2028)

12.1.4.  Market Revenue and Forecast, By Product (2016-2028)

12.1.5.  Market Revenue and Forecast, By Workflow (2016-2028)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Application (2016-2028)

12.1.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.1.6.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.1.6.4.      Market Revenue and Forecast, By Product (2016-2028)

12.1.6.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Application (2016-2028)

12.1.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.1.7.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.1.7.4.      Market Revenue and Forecast, By Product (2016-2028)

12.1.7.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Application (2016-2028)

12.2.2.  Market Revenue and Forecast, by End User (2016-2028)

12.2.3.  Market Revenue and Forecast, By Technology  (2016-2028)

12.2.4.  Market Revenue and Forecast, By Product (2016-2028)

12.2.5.  Market Revenue and Forecast, By Workflow (2016-2028)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Application (2016-2028)

12.2.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.6.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.2.6.4.      Market Revenue and Forecast, By Product (2016-2028)

12.2.6.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Application (2016-2028)

12.2.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.7.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.2.7.4.      Market Revenue and Forecast, By Product (2016-2028)

12.2.7.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Application (2016-2028)

12.2.8.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.8.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.2.8.4.      Market Revenue and Forecast, By Product (2016-2028)

12.2.8.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Application (2016-2028)

12.2.9.2.      Market Revenue and Forecast, by End User (2016-2028)

12.2.9.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.2.9.4.      Market Revenue and Forecast, By Product (2016-2028)

12.2.9.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Application (2016-2028)

12.3.2.  Market Revenue and Forecast, by End User (2016-2028)

12.3.3.  Market Revenue and Forecast, By Technology  (2016-2028)

12.3.4.  Market Revenue and Forecast, By Product (2016-2028)

12.3.5.  Market Revenue and Forecast, By Workflow (2016-2028)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Application (2016-2028)

12.3.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.6.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.3.6.4.      Market Revenue and Forecast, By Product (2016-2028)

12.3.6.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Application (2016-2028)

12.3.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.7.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.3.7.4.      Market Revenue and Forecast, By Product (2016-2028)

12.3.7.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Application (2016-2028)

12.3.8.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.8.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.3.8.4.      Market Revenue and Forecast, By Product (2016-2028)

12.3.8.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Application (2016-2028)

12.3.9.2.      Market Revenue and Forecast, by End User (2016-2028)

12.3.9.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.3.9.4.      Market Revenue and Forecast, By Product (2016-2028)

12.3.9.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Application (2016-2028)

12.4.2.  Market Revenue and Forecast, by End User (2016-2028)

12.4.3.  Market Revenue and Forecast, By Technology  (2016-2028)

12.4.4.  Market Revenue and Forecast, By Product (2016-2028)

12.4.5.  Market Revenue and Forecast, By Workflow (2016-2028)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Application (2016-2028)

12.4.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.6.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.4.6.4.      Market Revenue and Forecast, By Product (2016-2028)

12.4.6.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Application (2016-2028)

12.4.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.7.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.4.7.4.      Market Revenue and Forecast, By Product (2016-2028)

12.4.7.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Application (2016-2028)

12.4.8.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.8.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.4.8.4.      Market Revenue and Forecast, By Product (2016-2028)

12.4.8.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Application (2016-2028)

12.4.9.2.      Market Revenue and Forecast, by End User (2016-2028)

12.4.9.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.4.9.4.      Market Revenue and Forecast, By Product (2016-2028)

12.4.9.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Application (2016-2028)

12.5.2.  Market Revenue and Forecast, by End User (2016-2028)

12.5.3.  Market Revenue and Forecast, By Technology  (2016-2028)

12.5.4.  Market Revenue and Forecast, By Product (2016-2028)

12.5.5.  Market Revenue and Forecast, By Workflow (2016-2028)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Application (2016-2028)

12.5.6.2.      Market Revenue and Forecast, by End User (2016-2028)

12.5.6.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.5.6.4.      Market Revenue and Forecast, By Product (2016-2028)

12.5.6.5.      Market Revenue and Forecast, By Workflow (2016-2028)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Application (2016-2028)

12.5.7.2.      Market Revenue and Forecast, by End User (2016-2028)

12.5.7.3.      Market Revenue and Forecast, By Technology  (2016-2028)

12.5.7.4.      Market Revenue and Forecast, By Product (2016-2028)

12.5.7.5.      Market Revenue and Forecast, By Workflow (2016-2028)

Chapter 13.  Company Profiles

13.1.              Thermo Fisher Scientific Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Hoffmann-La Roche AG

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Qiagen N.V.

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Illumina, Inc.

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Genewiz

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Genscript Biotech Corporation

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              10x Genomics

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Macrogen, Inc.

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Agilent Technologies

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           BGI Genomics

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Fasteris SA

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           GE healthcare

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Report Details

  • Report Code:36925
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:January 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers